Order Article Reprints

Jolivet L, Ait Mohamed Amar I, Horiot C, Boursin F, Colas C, Letast S, Denevault-Sabourin C, Allard-Vannier E, Joubert N, Aubrey N. Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs). Pharmaceutics. 2022; 14(8):1524. https://doi.org/10.3390/pharmaceutics14081524

Jolivet, Louis, Imène Ait Mohamed Amar, Catherine Horiot, Fanny Boursin, Cyril Colas, Stéphanie Letast, Caroline Denevault-Sabourin, Emilie Allard-Vannier, Nicolas Joubert, and Nicolas Aubrey. 2022. "Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)" Pharmaceutics 14, no. 8: 1524. https://doi.org/10.3390/pharmaceutics14081524

Jolivet, L., Ait Mohamed Amar, I., Horiot, C., Boursin, F., Colas, C., Letast, S., Denevault-Sabourin, C., Allard-Vannier, E., Joubert, N., & Aubrey, N. (2022). Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs). Pharmaceutics, 14(8), 1524. https://doi.org/10.3390/pharmaceutics14081524